The illness sends tens of thousands of babies to the hospital each year. If approved, the new injection would be the first broadly available prevention tool.
Hong Kong banned cannibidiol, also known as CBD, as a "dangerous drug" and imposed harsh penalties for possession on Wednesday, forcing fledging businesses to shut down and revamp.
The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.
Thinking about the next pandemic is job number one for many researchers around the world. Here's a look at the World Health Organization's current list of pathogens with pandemic potential.
Advisers to the U.S. Food and Drug Administration today endorsed a proposal to make big changes in the nation's approach to vaccinating people against COVID-19.
The new approach would simplify vaccination guidance so that, every fall, people would get a new shot, updated to try to match whatever variant is dominant.
At-home rapid tests have become a staple of COVID-19 precautions, but some experts worry that people are relying too much on these tests and that's creating a false sense of security.
Roe author Mary Ziegler has chronicled the legal, political and cultural battles around abortion, and says the debate is far from over: "We're at the very beginning of something very confusing."
Getting abortion medication online is easier than ever thanks to regulatory changes. The practice is pushing the boundaries of the traditional doctor-patient relationship.
When first lady Jill Biden went for routine surgery for a small lesion above her right eye, doctors found two more lesions, and removed them, too, the White House said.
Instead of health insurance, the Rev. Jeff King had signed up for an alternative that left members of the plan to share the costs of health care. That meant lower premiums, but a huge hospital bill.
An Alzheimer's drug that removes the substance amyloid from the brain has received a conditional approval from the FDA. A large study found the drug decreased the loss of thinking and memory by 27%.
RSV and the flu appear to be receding in the U.S., but COVID is on the rise, new data suggests, driven by holiday gatherings and an even more transmissible omicron subvariant that has become dominant.
Changes by the FDA mean patients won't have to schedule in-person exams to get a prescription. That opens the door for more pharmacies to provide the medication. But not everyone will have access.
